Navigation Links
Taurine: Key to the visual toxicity of an anti-epileptic drug for children?
Date:2/17/2009

Vigabatrin (Sabril), first intention molecule for the treatment of epilepsy in children, in many cases produces secondary effects that lead to an irreversible loss of vision. Serge Picaud, head of research at Inserm, and his colleagues of the Institut de la Vision have just discovered the origin of this secondary effect and have proposed strategies for limiting it. They have shown that vigabatrin provokes a marked decrease in the blood level in an amino acid, taurine, resulting in a degeneration of the retina cells induced by light. The researchers therefore suggest that exposure to light should be reduced and a taurine-rich diet introduced in order to curb immediately these secondary effects in children undergoing treatment. As for the validation of an alternative treatment associating vigabatrin and taurine, this will necessitate several years of development.

This work is published in the review Annals of Neurology.

Epilepsy affects 1% of the world's population. With children, its treatment remains extremely restricted, and vigabatrin, (marketed in France under the name of Sabril), has obtained marketing authorisation for children aged under 2 years. This anticonvulsant, which is also administered to adults in the case of failure of other treatments, is at the same time now being evaluated for the treatment of addiction to heroin, cocaine and methamphetamines.

However, the serious secondary effects of this drug can induce an impairment of the retina and a restriction of the visual field, noted, depending on the studies, in 10% to 40% of patients.

In order to reach an understanding of this drug's modes of actions, and in particular the mechanism of visual function impairment, the Inserm researchers first of all administered vigabatrin to rats over a period of several months and analysed the influence of exposure to light during the treatment. The results show that there is no damage to the retina when the animals are kept
'/>"/>

Contact: Priscille Riviere
presse@inserm.fr
INSERM (Institut national de la sant et de la recherche mdicale)
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Moshi Names Independent Living Aids Exclusive Distributor in Blindness and Visual Impairment Field
2. Simple brain mechanisms explain arbitrary human visual decisions
3. Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors
4. Study suggests human visual system could make powerful computer
5. Hybrid Cars Pose Risk to Blind, Visually Impaired
6. Sign Language Associates and Visual Language Interpreting Combine With GoAmerica to Form Nations Premier Sign Language Interpreting Services Company
7. Photos: For the First Time Researchers Show Reversal of an Aging Marker in the Human Retina Correlated with Visual Improvement Using a Nutraceutical Matrix (Longevinex(R))
8. Edge Health Solutions Releases edgeDMS(TM) 2.0 and edgeMD 2.0(TM), Revolutionary All-in-One Practice Management Software with FDA-Approved Advanced Visualization
9. Michael J. Fox Foundation for Parkinsons Research Commits up to $2 million to Visualize Alpha-Synuclein Protein in the Brain
10. Sleep-Deprived Brains Show Lapse in Visual Processing
11. New Web Community Brings Together Parents of Visually Impaired Children

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...ss., Nov. 27 GSI Group I...r of precision technology products and semiconduct... of the Company,s shareholders has been scheduled ... of the meeting will be announced in due course. ...quisition notice from Stephen Bershad, a holder of...
(Date:11/27/2009)... 27 Considered a highly... years ago, solid organ transplantation is now a l...aordinary men and women who gathered at the Winspe...together from medical centers around the world to ...Transplant Institute (BRTI), one of the pioneers o...
(Date:11/27/2009)...R-SEINE, France, Nov. 27 Team Garm...ling team dedicated to ethical sporting and develo...ounced today that it will become Team Garmin-Trans... a new sponsor of the team. Transitions Optical is...ear, offering the most advanced photochromic techn...
(Date:11/27/2009)... low-emission vehicles may reduce future disease b...27 (HealthDay News) -- Encouraging city dwellers t...er much greater public health benefits than increa...s have found. , The study compared the projecte... transport scenarios for London, England, and Delh...
(Date:11/27/2009)... Voyant Health™ announced today that Spectr...s TraumaCad Enterprise orthopedic templating solut... (PRWEB) November 27, 2009...trum Health (Grand Rapids, Michigan) has licensed ...ution and its TraumaCad Extend workflow solution, ...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3
...y reserved for patients with Acute Myelogenous Le... transplantation graft failure or engraftme...id formulation; aims to restore US supplies o...on with the United States Food,and Drug Administra...
... faced with even a modest health insurance co-paym...eive these potentially life-saving breast cancer s...rsity and Harvard Medical School researchers. , I...s were 8 percent lower among women with a co-payme...
...,participating vendors raised $137,500 during its ...search and awareness at the Barbara Ann Karmanos,C...cgi-bin/prnh/20071106/KARMANOSCANCERINSTITUTELOGO ...ant cause," said Rick Going, president of The Krog...
...Benefit the National Breast ... response to underbanked,customers, demonstrated d...,Corp., one of the premier providers of prepaid so...cess(R) Visa(R),Prepaid Card to benefit the Nation...
...armaceutical Research & Development, L.L.C. announ...NDA) to the U.S. Food and Drug,Administration (FDA...IR),tablets, an investigational oral analgesic for...ear as a result of injuries or,surgeries, and a re...
...ategies for Aging Baby,Boomers, ALEXANDRIA, Va., ...tion in Florida, the nation,s leading professional...e presidential candidates,of both parties to addre...their families deserve to,know what the next presi...
Other Medicine News:Health News:Bayer Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation 2Health News:Bayer Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation 3Health News:Bayer Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation 4Health News:Health insurance co-payments deter mammography use 2Health News:Health insurance co-payments deter mammography use 3Health News:Kroger Pink Tag Campaign Raises $137,500 for Breast Cancer Research and Awareness at Karmanos Cancer Institute 2Health News:Kroger Pink Tag Campaign Raises $137,500 for Breast Cancer Research and Awareness at Karmanos Cancer Institute 3Health News:NetSpend(R) and ACE Cash Express Customers Keep Thinking Pink With the All-Access(R) Visa(R) Prepaid Card Program 2Health News:NetSpend(R) and ACE Cash Express Customers Keep Thinking Pink With the All-Access(R) Visa(R) Prepaid Card Program 3Health News:NetSpend(R) and ACE Cash Express Customers Keep Thinking Pink With the All-Access(R) Visa(R) Prepaid Card Program 4Health News:New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets 2Health News:New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets 3Health News:New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets 4Health News:Assisted Living Federation Challenges Presidential Candidates 2
(Date:11/24/2009)... 24 /PRNewswire-Asia/ -- Chindex International, In...dent American provider of Western,healthcare produ..., today,announced that the Company will attend the... Conference, to be held December 1 - 2, 2009, at t... currently scheduled to present at 11:30 am ET on ...
(Date:11/24/2009)...ewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: EL...or aortic disorders, announced today that it has f...ngs in, the patent infringement lawsuit brought ag... was filed in the United States District Court in ...ed that the stay remain in effect while the United...
(Date:11/24/2009)...Newswire-FirstCall/ -- Vermillion, Inc. (VRML) (Pi...Plan of Reorganization and Disclosure Statement to...kruptcy Court for the District of Delaware. A hear...nt is presently scheduled for December 8, 2009, wi...eduled for January 7, 2010. ,, The Plan calls ...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Vermillion Files Plan of Reorganization 4Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo 28R 29 Complete Response Letter 6484 1Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo 28R 29 Complete Response Letter 6484 2News brief 3A Arsenic biomethylation required for oxidative DNA damage 61985 1Children who lack continuity with a regular health care provider miss needed services 61983 1Children who lack continuity with a regular health care provider miss needed services 61983 2Children who lack continuity with a regular health care provider miss needed services 61983 3
....C.--(BUSINESS WIRE)--Apr 25, 2007 - BioDelivery,S...ed today,statistically significant results with BE...gh pain in its pivotal Phase III efficacy,clinical...chievement of the primary efficacy endpoint of the...), compared to placebo., The results demonstrated ...
... 25, 2007 /PRNewswire-USNewswire/ -- At least,one-...r first,appear in childhood or adolescence. Howeve... bipolar symptoms from those of other,disorders, n...th,Letter. , Children, especially young children, ...od episodes of mania and depression.,Also, many sy...
Other Medicine Technology:BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 2BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 3BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 4BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 5BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 6Bipolar Disorder in Children Difficult to Diagnose, Reports the,Harvard Mental Health Letter 2
Tabers Cyclopedic Medical Dictionary 20th edition
The American Heritage® Stedman's Medical Dictionary
ICD Meister™
MD Coder Web Edition 2006
Medicine Products: